Navigation Links
Delcath to Present at the 2010 Wedbush Securities Life Sciences Best Ideas Management Access Conference
Date:7/28/2010

liver cancers.  Delcath recently concluded a Phase III metastatic melanoma study, and the Company is currently conducting a multi-arm Phase II trial to treat other liver cancers. The Company has not yet received FDA or any foreign regulatory approval for commercial sale of its system.  For more information, please visit the Company's website at www.delcath.com.  

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the acceptability of the Phase III clinical trial data by the FDA, our ability to successfully complete an FDA new drug application, acceptance of the new drug application by the FDA, approval by the FDA or other regulatory authorities of the current or future drug delivery system for the treatment of metastatic melanoma, our ability to successfully complete other clinical trials and secure regulatory approval of our current or future drug-delivery system for the treatment of other liver cancers and other organs, the potential of chemosaturation therapy via PHP as a treatment for patients with terminal metastatic disease in the liver, actions by the FDA or other regulatory agencies  and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Systems Announces Second Quarter Progress Report Conference Call
2. Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago
3. Delcaths Eamonn Hobbs to Ring NASDAQ Opening Bell
4. Delcath Systems Provides Update on Corporate Developments
5. Delcath Signs First Partner Agreement in Asia
6. Delcath Systems Begins Data Analysis of Phase III Trial
7. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
8. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
9. Delcath Systems Reports Substantial Progress
10. Delcath Systems Announces Completion of Public Offering
11. Delcath Systems, Inc. Prices $30.6 Million Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 Eli Lilly ... Goldman Sachs 36th Annual Global Healthcare Conference on Tuesday, ... president and president, Elanco Animal Health, will participate in ... A live audio webcast will be ... investor website at http://investor.lilly.com/events.cfm . A replay of ...
(Date:5/29/2015)... and SPARTANBURG, South Carolina , ... Research Network and Molecular Health have announced a collaboration ... diagnostic decision support to the majority of cancer patients ... Network will collaborate with Molecular Health to harness the ... identify cohorts from hundreds of thousands of patients to ...
(Date:5/29/2015)... 2015 Research and Markets ... the "Surgical/Operating Microscopes Market by Application & ... report to their offering.      (Logo: ... is poised to reach $806.6 million by 2020 ... of 12.3% from 2015 to 2020. , ,Major ...
Breaking Medicine Technology:Lilly to Participate in Goldman Sachs Global Healthcare Conference 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
(Date:5/29/2015)... PA (PRWEB) May 29, 2015 M3 ... quiz-based learning in 14 medical specialties, now offers ... a wide spectrum of rheumatology disorders ranging from Fibromyalgia ... Saint Jacques, editorial director of MDLinx, and Caroline Tredway, ... about the impact it will have on the physicians ...
(Date:5/29/2015)... The science of Follicular Unit Extraction ... and more efficient methods of FUE hair transplantation have increased ... of the most cutting edge hair transplant methods being used ... technique of extracting hair from the beard to the scalp. ... to correct male pattern baldness. Beard hair has a ...
(Date:5/29/2015)... 2015 Jan Wooden Howse lost her husband ... above all else: God does no wrong. , It’s fitting, ... son’s passing is titled “God Does No Wrong.” It focuses ... great personal tragedy. , “My story has a positive ... you into something productive, something healing,” Howse said. , “God ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 World Patent ... products, announces that it has signed a 10 year ... patent that aims to let people learn about any ... real time. , "This is an exciting day for ... said Scott J. Cooper, CEO and Creative Director of ...
(Date:5/29/2015)... 29, 2015 Mediaplanet has joined forces ... protection”. Skin Health is a cross-platform campaign with ... markets of New York, Los Angeles, and Chicago, the ... Its digital counterpart will reach a national audience through ... more the Skin Health campaign and Colorescience, click ...
Breaking Medicine News(10 mins):Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Turning grief from a child’s passing into virtue 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2
... in the October 2009 issue of the Journal ... of positron emission tomography (PET)/computed tomography (CT) (PET/CT) tests ... This novel approach to the diagnosis of lung cancer ... (82%). The fast track model tests patients for lung ...
... issue of the Journal of Bone and Joint Surgery ... with a spine or hip fracture are managed and evaluated. ... in Korea, reviewed the incidence of fractures around the hip, spine, ... prescription frequencies of bone density scans for osteoporosis, along with the ...
... extensive burns die of the consequences of a severe ... International ( Dtsch Arztebl Int 2009; 106[38]: ... and his coauthors discuss the acute therapy and follow-up ... severely burned patients necessitates collaboration between primary care physicians, ...
... disturbances , THURSDAY, Oct. 1 (HealthDay News) -- If ... pregnancy, researchers now say that tobacco use by expectant ... develop psychotic symptoms. , The new research, published in ... Psychiatry , doesn,t prove that smoking during pregnancy causes ...
... with New York Times Ad , WASHINGTON, Oct. 1 ... in the New York Times , continuing its million dollar ad ... yourself fat" PSA campaign. The Center will also continue to run ads ... Post that ask New Yorkers, "What,s Next?" and "Big Apple or ...
... Today, MSN released the beta ... people manage their health information on the Web. My Health ... of tools and widgets to upload, organize and monitor health ... service allows people to research medical concerns, read the latest ...
Cached Medicine News:Health News:Wrist fracture patients less likely to be evaluated for osteoporosis 2Health News:Smoking in Pregnancy Linked to Psychotic Symptoms in Kids 2Health News:Consumer Group Continues Million Dollar Campaign Responding to NYC Health Officials' Hyperbolic PSA Campaign 2Health News:MSN Introduces Online Tools to Help People Make Smarter Health and Lifestyle Decisions 2Health News:MSN Introduces Online Tools to Help People Make Smarter Health and Lifestyle Decisions 3
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... 3-Point® Polycentric Hinged Ulnar Deviation Splint ... align the hand with ulnar deviation at ... impede grasp or pinch. Radial and ulnar ... ensure unimpeded flexion and extension. Padded, malleable ...
... immobilizes and positions the elbow at 122 ... prominent. Restricts full extension and flexion to ... helps prevent pain and irritation due to ... post-cast removal. Rigid, high-density beige polyethylene shell ...
... Orthosis For quick, efficient immobilization of ... immobilizes and protects the fracture and ... comfort, support, and conformity to the ... shell may be gently heated (with ...
Medicine Products: